Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645575 · ClinicalTrials.gov registry record · NA

In-patient SCC TMS

A NA study of Major Depressive Disorder, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05645575 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645575, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators are studying the feasibility, safety, and tolerability of administering accelerated repetitive Transcranial magnetic stimulation(a-rTMS) at frequencies other than standard 10 Hz for in-patient Subjects diagnosed with Major Depressive Disorder. Participants will be recruited from the Resnick Neuropsychiatric Hospital. This study will enroll 30 participants who will undergo up to three brain activity recordings, one MRI scan, one TMS procedure to determine the appropriate frequency and intensity for treatment, daily symptom assessments, and 25 TMS treatments. Participants will be asked to participate for up to 2 weeks.

Conditions Studied

Interventions

  • DEVICE Open-label TMS

Study Locations (1)

California

  • UCLA TMS Service and Research Service - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-04-01
Est. Completion 2027-02-22
Phase NA

What the Registry Record Tells You About NCT05645575

The ClinicalTrials.gov registry entry for NCT05645575 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (92% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Open-label TMS is the first listed.

NCT05645575 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05645575 about?

NCT05645575 is a clinical study titled "In-patient SCC TMS". The investigators are studying the feasibility, safety, and tolerability of administering accelerated repetitive Transcranial magnetic stimulation(a-rTMS) at frequencies other than standard 10 Hz for in-patient Subjects diagnosed with Major Depressive Disorder. Participants will be recruited from th...

What is the current status of trial NCT05645575?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-01. Estimated completion is 2027-02-22.

What conditions does trial NCT05645575 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT05645575?

The interventions under investigation include: Open-label TMS (DEVICE).

Who is sponsoring clinical trial NCT05645575?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645575 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.